AdipoGen Life Sciences Notch signalling research reagents

Wednesday, 31 May, 2017 | Supplied by: Sapphire Bioscience


The Notch signalling pathway regulates many different cell fate decisions in both vertebrate and invertebrate species. Deregulations in Notch signalling components have been associated with various human disorders such as cancer, immune disorders, developmental syndromes, stroke and cognitive symptoms.

AdipoGen Life Sciences brings a comprehensive range of Notch signalling reagents to the market. Products include Notch receptors (Notch 1 and 2), canonical Notch ligands (DLL1, DLL3 and DLL4), non-classical Notch ligands (DLK1 and DLK2), E3 ubiquitin ligases, deubiquitinating enzymes and Notch inhibitors.

The reagents are suitable for scientists requiring tools for cancer, T cell and developmental biology research.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

ProImmune ProVE SL Self-Loading MHC Class I Monomers

The novel reagents for antigen-specific CD8+ T cell detection are designed to offer...

HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits

HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...

Amsbio validated cytokines for organoid culture

Amsbio has launched over a range of over 30 independently developed and manufactured organoid...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd